{
    "clinical_study": {
        "@rank": "161426", 
        "acronym": "Potato", 
        "arm_group": [
            {
                "arm_group_label": "Placebo control", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Subjects will consume tablets containing no potassium in addition to a basal diet containing 2336 mg potassium"
            }, 
            {
                "arm_group_label": "Low dose potassium gluconate", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will consume 720 mg potassium in the form of potassium gluconate tablets daily in addition to a basal diet containing 2336 mg potassium"
            }, 
            {
                "arm_group_label": "Medium dose potassium gluconate", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will consume 1440 mg potassium in the form of potassium gluconate tablets daily in addition to a basal diet containing 2336 mg potassium"
            }, 
            {
                "arm_group_label": "High dose potassium gluconate", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will consume 2160 mg potassium in the form of potassium gluconate tablets daily in addition to a basal diet containing 2336 mg potassium"
            }, 
            {
                "arm_group_label": "Low dose potato", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will consume 720 mg potassium in the form of potato daily in addition to a basal diet containing 2336 mg potassium"
            }, 
            {
                "arm_group_label": "Medium dose potato", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will consume 1440 mg potassium in the form of potato daily in addition to a basal diet containing 2336 mg potassium"
            }, 
            {
                "arm_group_label": "High dose potato", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will consume 2160 mg potassium in the form of potato daily in addition to a basal diet containing 2336 mg potassium"
            }, 
            {
                "arm_group_label": "High dose French fries", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will consume 2160 mg potassium in the form of french fries daily in addition to a basal diet containing 2336 mg potassium"
            }, 
            {
                "arm_group_label": "Basal diet control", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will consume a basal diet containing 2336 mg potassium daily"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is designed to compare the effect of sources of potassium on uptake and the\n      effect of potassium on blood pressure."
        }, 
        "brief_title": "Bioavailability of Potassium From Potatoes and Potassium Gluconate", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Potassium Bioavailability", 
            "Blood Pressure"
        ], 
        "detailed_description": {
            "textblock": "The study will compare uptake of potassium from three different doses and sources;\n      supplements (720, 1440 and 2160 mg) potatoes (720, 1440 and 2160 mg) or French fries (2160\n      mg).\n\n      During 9 phases, participants will consume a controlled diet with the supplements, potato or\n      french fries (every other week for 5 days). On the 4th day, blood and urine samples will be\n      taken to monitor potassium uptake and excretion.  Measures of blood pressure will be\n      analyzed at defined time points throughout the intervention."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Able to adhere to the visit schedule, protocol requirements and available to\n             complete the study\n\n          -  Normotensive men and women\n\n          -  Aged 20-60 years\n\n          -  BMI of 15-35\n\n        Exclusion Criteria:\n\n          -  Medication to treat hypertension or hypotension\n\n          -  Medication known to affect electrolyte metabolism or contain high levels of potassium\n             or sodium\n\n          -  smoke cigarettes or use illegal drugs\n\n          -  Hypertension or hypotension\n\n          -  Diseases known to affect potassium metabolism\n\n          -  Pregnant\n\n          -  Allergic to nuts"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "35", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 17, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01881295", 
            "org_study_id": "1301013174"
        }, 
        "intervention": [
            {
                "arm_group_label": "Placebo control", 
                "intervention_name": "Placebo control", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Low dose potassium gluconate", 
                "intervention_name": "Low dose potassium gluconate", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Medium dose potassium gluconate", 
                "intervention_name": "Medium dose potassium gluconate", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "High dose potassium gluconate", 
                "intervention_name": "High dose potassium gluconate", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Low dose potato", 
                "intervention_name": "Low dose potato", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Medium dose potato", 
                "intervention_name": "Medium dose potato", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "High dose potato", 
                "intervention_name": "High dose potato", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "High dose French fries", 
                "intervention_name": "High dose French fries", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Basal diet control", 
                "intervention_name": "Basal diet control", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Potassium", 
            "Potato", 
            "French Fries", 
            "Bioavailability", 
            "Blood Pressure"
        ], 
        "lastchanged_date": "June 17, 2013", 
        "location": {
            "contact": {
                "email": "bmartin1@purdue.edu", 
                "last_name": "Berdine R Martin, Ph.D.", 
                "phone": "765-494-6559"
            }, 
            "facility": {
                "address": {
                    "city": "West Lafayette", 
                    "country": "United States", 
                    "state": "Indiana", 
                    "zip": "47907"
                }, 
                "name": "Purdue University"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "9", 
        "official_title": "Bioavailability of Potassium From Potatoes and Potassium Gluconate", 
        "overall_contact": {
            "email": "bmartin1@purdue.edu", 
            "last_name": "Berdine R Martin, Ph.D.", 
            "phone": "765-494-6559"
        }, 
        "overall_contact_backup": {
            "email": "macdonc@purdue.edu", 
            "last_name": "Claire J Macdonald-Clarke, Ph.D.", 
            "phone": "765-494-7625"
        }, 
        "overall_official": [
            {
                "affiliation": "Purdue University", 
                "last_name": "Connie M Weaver, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Purdue University", 
                "last_name": "Berdine R Martin, Ph.D.", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "After 4 days of acclimation to the supplementation, absorption of potassium will be measured.", 
            "measure": "Bioavailability of Potassium", 
            "safety_issue": "No", 
            "time_frame": "5 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01881295"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Differences in blood pressure will be measured between levels of potassium consumption.", 
            "measure": "Blood Pressure Response to Potassium", 
            "safety_issue": "No", 
            "time_frame": "6 days"
        }, 
        "source": "Purdue University", 
        "sponsors": {
            "collaborator": {
                "agency": "Alliance for Potato Research and Education (APRE)", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Purdue University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject)", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}